Epidemiology of Hypophosphatemia in Critical Illness: A Multicentre, Retrospective Cohort Study.

Critical illness Electrolyte imbalance Hypophosphatemia Multicentre Phosphate replacement

Journal

Anaesthesia, critical care & pain medicine
ISSN: 2352-5568
Titre abrégé: Anaesth Crit Care Pain Med
Pays: France
ID NLM: 101652401

Informations de publication

Date de publication:
30 Jul 2024
Historique:
received: 08 05 2024
revised: 09 07 2024
accepted: 14 07 2024
medline: 2 8 2024
pubmed: 2 8 2024
entrez: 1 8 2024
Statut: aheadofprint

Résumé

Hypophosphatemia is common in critically ill patients. We have described the epidemiology of hypophosphatemia in patients admitted to the Intensive Care Units. A multicentre, retrospective cohort study of 12 ICUs in Queensland, Australia from January 1st, 2015, to December 31st, 2021. Exclusions included readmissions, renal replacement therapy, end-stage renal disease, and palliative intent admissions and transfers from other ICUs. Patients were classified into four groups based on the severity of the first episode of low serum phosphate (PO Of the 89,776 patients admitted, 68,699 patients were included in this study, with 23,485 (34.2%) having hypophosphatemia with onset mostly on Day 2 of ICU admission and correcting to normal 3 days after hypophosphatemia was identified. There was substantial variation among participating ICUs in phosphate replacement; the threshold, and the route by which it was replaced. Day-90 case fatality increased with severity of hypophosphatemia (None: 3,974 (8.8%), Mild: 2,306 (11%), Moderate: 377 (14%); Severe: 108 (21%) (p < 0.001)). Multivariable regression analysis showed that compared to those without hypophosphatemia, patients with moderate (odds ratio (OR) 1.24; 95% confidence intervals (CI) 1.07-1.44; p = 0.004) or severe (OR 1.49; 95% CI 1.13-1.97; p = 0.005) hypophosphatemia had increased risk of 90-day case fatality. Hypophosphatemia was common, and mostly occurred on day 2 with early correction of serum phosphate. Phosphate replacement practices were variable among ICUs. Moderate and severe hypophosphatemia was associated with increased 90-day case fatality.

Identifiants

pubmed: 39089453
pii: S2352-5568(24)00068-7
doi: 10.1016/j.accpm.2024.101410
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101410

Informations de copyright

Copyright © 2024. Published by Elsevier Masson SAS.

Auteurs

Antony George Attokaran (AG)

Intensive Care Unit, Rockhampton Hospital, Rockhampton, Queensland, Australia; University of Queensland, Rural Clinical School, Rockhampton, Queensland, Australia. Electronic address: antony.attokaran@health.qld.gov.au.

Kyle C White (KC)

Intensive Care Unit, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia; Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.

Ra'eesa Doola (R)

Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia; Centre for Functioning and Health Research, Metro South Health, Queensland, Australia; Nutrition and Dietetics, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.

Philippa McIlroy (P)

Intensive Care Unit, Cairns Hospital, Cairns, Queensland, Australia.

Siva Senthuran (S)

Intensive Care Unit, Townsville Hospital, Townsville, Queensland, Australia; College of Medicine and Dentistry, James Cook University, Townsville, Queensland, Australia.

Stephen Luke (S)

Intensive Care Services, Mackay Base Hospital, Mackay, Queensland, Australia.

Peter Garrett (P)

Intensive Care Unit, Sunshine Coast University Hospital, Birtinya, Queensland, Australia; School of Medicine and Dentistry, Griffith University, Mount Gravatt, Queensland, Australia.

Alexis Tabah (A)

Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia; Intensive Care Unit, Redcliffe Hospital, Brisbane, Queensland, Australia; Queensland University of Technology (QUT), Brisbane, Queensland, Australia.

Kiran Shekar (K)

Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia; Adult Intensive Care Services, the Prince Charles Hospital, Brisbane, Queensland, Australia.

Felicity Edwards (F)

Queensland University of Technology (QUT), Brisbane, Queensland, Australia; Department of Intensive Care Services, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.

Hayden White (H)

School of Medicine and Dentistry, Griffith University, Mount Gravatt, Queensland, Australia; Intensive Care Unit, Logan Hospital, Logan, Queensland, Australia.

James Pa McCullough (JP)

Intensive Care Unit, Gold Coast University Hospital, Southport, Queensland, Australia.

Rod Hurford (R)

Intensive Care Unit, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.

Pierre Clement (P)

Department of Intensive Care Services, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.

Kevin B Laupland (KB)

Queensland University of Technology (QUT), Brisbane, Queensland, Australia; Department of Intensive Care Services, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.

Mahesh Ramanan (M)

Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia; Adult Intensive Care Services, the Prince Charles Hospital, Brisbane, Queensland, Australia; Intensive Care Unit, Caboolture Hospital, Caboolture, Queensland, Australia; Critical Care Division, The George Institute for Global Health, University of New South Wales, Sydney, Australia.

Classifications MeSH